Pharmaceuticals Acquisitions in Missouri
Showing 2 transactions.
-
- Buyer
- ANI Pharmaceuticals, Inc.
- Target
- Four ANDAs (from Oakrum Pharma, LLC)
- Seller
- Oakrum Pharma, LLC
- Industry
- Pharmaceuticals
- Location
- Missouri, United States
- Type
- Divestiture
ANI Pharmaceuticals, Inc. acquired four abbreviated new drug applications (ANDAs) from Oakrum Pharma, LLC in an asset purchase announced July 28, 2022. The acquisition expands ANI's generics product portfolio and is intended to enable product launches and revenue contribution beginning in 2023.
-
November 19, 2019
- Buyer
- Farragut Capital Partners, BroadOak Capital Partners
- Target
- Particle Dynamics, Inc.
- Seller
- Edgewater Capital Partners
- Industry
- Pharmaceuticals
- Location
- Missouri, United States
- Type
- Growth capital
Farragut Capital Partners led a growth investment in Particle Dynamics, Inc., joined by BroadOak Capital Partners; Particle Dynamics is a portfolio company of Edgewater Capital Partners. The capital will support the company's growth and capability expansion across its particle processing, microencapsulation and finished-dosage manufacturing services operating from FDA‑inspected facilities in St. Louis, Missouri and Seymour, Indiana.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.